Lu-Tex: PCYC expanded the Phase I dose-ranging trial to a third site

Pharmacyclics Inc. (PCYC), Sunnyvale, Calif. Product: Lu-Tex, lutetium-texaphryrin photosensitizer Indication: Cancer accessible to externally applied light (melanoma, Kaposi's sarcoma, breast cancer)...